<DOC>
	<DOCNO>NCT01611883</DOCNO>
	<brief_summary>This study examine effect ezetimibe glucose metabolism participant Type 2 diabetes hypercholesterolemia.The primary hypothesis change glycated hemoglobin ( HbA1c ) baseline ezetimibe treatment group non-inferior placebo control group .</brief_summary>
	<brief_title>A Study Effect Ezetimibe Glucose Metabolism Type 2 Diabetics With Hypercholesterolemia ( P06541 )</brief_title>
	<detailed_description />
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Ezetimibe</mesh_term>
	<criteria>Have hypercholesterolemia ( high cholesterol ) diagnose type 2 diabetes treat oral antidiabetic drug insulin . No change medication ( drug , dose administration ) treatment diabetes within previous 12 week exception small change insulin dose No change diet exercise therapy within previous 4 week Coexisting disease ( hemoglobinopathy , hemolytic anemia , etc . ) may affect HbA1c measurement Homozygous heterozygous familial hypercholesterolemia Previously receive ezetimibe Hypercholesterolemia associate : hypothyroidism , obstructive gall bladder biliary disease , chronic renal failure pancreatitis Hyperlipidemia cause medication</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>